Esperion Therapeutics (ESPR) Appoints Stephen Rocamboli to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. NVDA
2. BAC
3. DPZ
4. GS
5. UNH
6. ORCL
7. DRS
8. JPM
9. ACI
10. CRWV

Go back to Esperion Therapeutics (ESPR) Appoints Stephen Rocamboli to its Board

Esperion Announces the Appointment of Stephen Rocamboli to its Board of Directors

April 28, 2022 4:00 PM EDT

ANN ARBOR, Mich., April 28, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the appointment of Stephen Rocamboli as a Class I director, with a term expiring at the 2023 annual meeting of stockholders. Mr. Rocamboli fills the newly created vacancy resulting from Dr. Mark McGoverns retirement from the Board.

"On behalf of the Esperion team and our directors, I am very pleased to welcome Stephen to the Esperion Board. Stephens extensive experience as a senior business and legal executive for multiple public life science organizations will be a great asset for Esperion as... More